Their contention revitalizes the therapeutic concept of raising HDL cholesterol levels to reduce the risk of cardiovascular events in patients being effectively treated with LDL-cholesterol ...
“Risk does seem to decline as HDL rises to around the eightieth percentile,” Dr. Attia writes. “But simply raising HDL cholesterol concentrations by brute force, with specialized ...
Recipients of twice-daily torcetrapib saw a cumulative mean 65% reduction in CETP activity and a 106% increase in HDL (from 34 mg/dL to 70 mg/dL). All CETP and HDL changes were significant.
also showed a correlation between HDL-c and dementia, with a 15% increased risk in people with levels above 65 mg/dL and a 7% increase in those with very low levels (11 to 41 mg/dL). It’s worth ...